Berkshire Hathaway Makes Major Portfolio Shift New Stakes in Delta Air Lines and Alphabet Bank Holiday Sunshine Drives Tourism Boost in Devon and Cornwall Amazons Potential Path to 20 Appreciation A Cautious Look at Key Drivers Judge Dismisses Criminal Case Against Wrongfully Deported Individual Potential Implications for Immigration Enforcement and Corporate Liability SoFi Technologies and Ally Financial A Comparative Analysis of Online Banking Platforms Fresh US Strikes Complicate Iran Deal Geopolitical Risk Resurfaces TCBX Q1 2026 Earnings EPS Beats Estimates by 363 as Net Interest Income Drives Performance VSNT Q1 2026 Earnings EPS Surges Past Estimates with 949 Beat CCG Q4 2024 Earnings Narrowerthanexpected loss drives positive surprise despite stock decline DRCT Q1 2026 Earnings Narrowing Losses as EPS Surprises to the Upside NervGen Pharma Q3 2025 Earnings Narrowed Loss Meets Estimates But Stock Plunges 43 SPS Commerce Q1 2026 Earnings EPS Surprises to the Upside as Operating Discipline Supports Bottom Line Bitcoin Infrastructure Acquisition Corp BIXI Holds Steady at 997 Consolidation in Focus Civista Bancshares CIVB Gains 14 as Regional Bank Stock Approaches Key Resistance Level Scage Future SCAG Surges 834 Testing Key Resistance at 057 Isabella Bank ISBA Slips Slightly Holds Above Key Support at 4089 QVCD Holds Steady at 1010 as Bond Market Navigates Mixed Signals Rise in Solar Panel Sales Driven by Energy Cost Concerns FITBM Q1 2026 Earnings Preferred Stock EPS Surges Past Estimates on Strong Bank Performance Fidelity D D Bancorp FDBC Edges Higher as Stock Hovers Near Key Support Zone Defi Technologies Inc DEFT Sees Modest Decline Amid Broader Crypto Sector Volatility ACGLN Preferred Shares Edge Higher Amid Steady Income Demand MeiraGTx MGTX Surges 3 Gene Therapy Player Tests Resistance at 1038 Zeta Global ZETA Surges 4 as Bullish Momentum Builds Above Key Support Brighthouse Financial 625 Junior Subordinated Debentures BHFAL Edges Higher Nearing Key Resistance Netcapital Inc Warrants NCPLW Surge Over 17 A Closer Look at the Tight Trading Range Nurix Therapeutics NRIX Rallies 230 as Buyers Test Resistance Near 1867